Explore more publications!

International Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.

Press releases published on April 10, 2026

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings
Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings
Insyrt: Neue PR-Agentur für B2B-Tech-Unternehmen vereint 20 Jahre PR-Erfahrung mit Generative Engine Optimization (GEO)
Pelthos Therapeutics Announces CFO Transition
JIADE LIMITED Announces Fiscal Year 2025 Financial Results
Direct Marketing Firm Azul Connections Inc. Successfully Relocates Operations to Las Vegas and Expands Team
PulsePoint Strategies Showcase Leadership Development With 2 Promotions in 12 Weeks, Expands Hiring
SPiCE Series 2026: A Global Calendar of Strategic Industry Engagement
SBC Summit Americas: Understanding the Forces Shaping Latin America’s Betting and Casino Markets
GammaStack Shortlisted for Three Major Industry Awards Across Casino and Sports Betting Platform Categories
CLUE Brings AI to the Jobsite with New Fleet Intelligence Suite
WebDaddy Pro Launches Certified SBA Vendor Website Initiative, Supporting SBA‑Certified Small Businesses Nationwide
Arqit Quantum Inc. Announces Select Preliminary Financial Results for the First Half of Fiscal Year 2026
The Sports Betting East Africa+ Summit Expands with High-Impact Start-Up Pitch Competition
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION
New Era Energy & Digital Announces Change of Date of Special Meeting of its Stockholders
Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions